Dyax

Showing 1 posts of 1 posts found.

Shire

Shire to acquire Dyax in $5.9 billion deal

November 2, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Dyax, M&A, MA, R&D, Shire, hereditary angioedema, rare disease

Shire has struck a deal to acquire the biotech firm Dyax for $5.9 billion, in order to acquire exclusive rights …

The Gateway to Local Adoption Series

Latest content